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Large tumor of iliac bone in a young woman imitating malignant disease 
as a sign of primary hyperparathyroidism
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Detection of a bone tumor in a young adult draws suspicion of neoplastic disease. 
A 22-year-old female was admitted for a bone tumor biopsy. MRI of the pelvis showed an osteolytic lesion at the level 
of the left sacroiliac joint. Radiologist suggested differential diagnosis between aneurysmal bone cyst and giant cell 
tumor of bone. Considering the high serum calcium and numerous foci of increased accumulation of the radioisotope 
on the bone scan, serum iPTH level was evaluated. The diagnosis of hyperparathyroidism was established. Neck ultra-
sound revealed focal lesion corresponding to an enlarged parathyroid gland. Parathyroidectomy was performed. The 
iliac bone tumor showed to be a brown tumor of primary hyperparathyroidism, detected only rarely in adolescents. 
Non-specific symptoms and lack of routine control of serum calcium in youths make an early diagnosis difficult; 
moreover, pathological features of brown tumor and giant cell tumor of bone are very similar.
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Introduction
A bone tumor can be a benign or a malignant neoplastic 
lesion or even a result of non-neoplastic condition. The inciden-
ce of benign bone neoplasms is higher than the one of primary 
malignant tumors. In addition, primary malignant bone tumors 
are outnumbered by metastases from carcinomas, melanoma, 
or hematologic malignancies, such as plasmacytoma [1]. 
The age-specific incidence rates of bone sarcomas show 
a bimodal distribution, with the first peak in the second 
decade, and the other after the sixth decade of life. Ewing 
sarcoma and osteosarcoma are the most frequent histologic 
subtypes in the first two decades, while chondrosarcoma, 
malignant fibrous histiocytoma, chordoma and secondary 
osteosarcoma show an increased incidence after the fourth 
decade of life [1]. 
As some types of malignant bone tumors affect mostly 
young people, bone lump found in a young person neces-
sitates urgent diagnostic workup.
The osseous pelvis is a well-recognized site of primary 
and secondary musculoskeletal tumors [2]. Patients with 
pelvic tumor are usually older than the ones with tumors 
in extremities, and the lesions found are most often larger. 
The majority of tumors in the pelvis are malignant [3, 4]. 
Some tumor-like lesions occurring in the hip and pelvis may 
mimic neoplasm, e.g.: infections (including tuberculosis), 
insufficiency/avulsion fractures, cysts, fibrous dysplasia, 
aneurysmal bone cyst, Langerhans cell histiocytosis, and 
Paget’s disease [3]. 
Another medical condition, which can lead to the bone 
deformity within the pelvic girdle, is an osteitis fibrosa cys-
tica (OFC) resulting from hyperparathyroidism, uncom-
monly diagnosed among adolescents and young adults 
[5]. Excessive parathyroid hormone (PTH) secretion from 
e.g. parathyroid adenoma accelerates bone turnover with
predominating osteoclastic activity. Succeeding intensive
bone resorption together with intraosseus bleeding and
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tissue degeneration may lead to the formation of cystic 
lesions filled with hemosiderin-loaded macrophages, giant 
cells, and fibroblasts. Hemosiderin deposits, hemmorhages 
and vascularization give brown colour to the soft-tissue 
component of the tumor [6]. Signs and symptoms of hy-
perparathyroidism from musculoskeletal system include 
bone pain and deformities, pathological fractures, proximal 
muscle weakness with hyperreflexia [7]. These complaints 
are characteristic in older groups. Brown tumors, represent-
ing the terminal stage of the bone remodeling process, can 
be located in any part of skeleton (but most frequently in 
the jaws, ribs, clavicles, extremities, pelvis). They are rare 
manifestations of prolonged hyperparathyroidism with an 
overall incidence of 2–3% [8].
The radiologic evaluation of a pelvic lesion often begins 
with the plain film and proceeds to computed tomography 
(CT) or magnetic resonance imaging (MRI) [2]. CT plays 
more important role in visualizing incidental findings and 
in characterizing tumor-like lesions, such as normal variants 
and post-traumatic sequelae. MR is the primary preoperative 
staging tool for sarcoma, as well as the most reliable one to 
detect tumor recurrence, especially in locations inaccessible 
by clinical examination, as pelvis [3, 9]. Clinical history and 
imaging characteristics can significantly narrow the broad 
differential diagnosis for osseous pelvic lesions [2].
Case presentation 
A 22-year-old woman was admitted to the Maria 
Skłodowska-Curie Institute — Oncology Center in Warsaw 
because of a tumor in the left iliac bone she had noticed 
4 weeks before. The MRI of lumbo-sacral region showed an 
osteolytic lesion containing fluid and soft tissue component 
(Fig. 1). Differential diagnosis between aneurysmal bone 
cyst and giant cell tumor of bone was suggested by the 
radiologist. 
The patient reported unexpected weight loss of 10 kg 
when she was 18, followed by lack of appetite, frequent 
nausea, excessive thirst and by migrating bone and joints 
pain. The patient decided to see a doctor, when she noticed 
a tumor in the pelvis. On admission, the patient was under-
weight (BMI 13.8 kg/m2). There was an 8 cm palpable tumor 
in the sacroiliac area. 
The patient’s age, clinical manifestation and imaging re-
sults suggested a neoplastic disease. The planned diagnostic 
workup included: laboratory blood tests, a three-phase 
bone scintigraphy and then a probe-guided bone biopsy 
of the tumor. Soft-tissue phase of bone scanning revealed 
increased accumulation of the tracer in peripheral part of 
the iliac bone tumor, while numerous foci of pathological 
radioisotope uptake in the skeleton were shown at the 
delayed phase of bone scintigraphy (Fig. 2). Meanwhile 
results of lab tests were obtained. As hypercalcemia (4.11 
mmol/l, normal range: 2.2–2.65 mmol/l) was revealed, the 
laboratory panel has been broadened into intact parathy-
roid hormone (iPTH) and phosphate levels (Tab. I). At this 
point a probe-guided biopsy of the tumor in the left iliac 
bone was performed (Fig. 3). 
The results of the medical diagnostic examination point-
ed to primary hyperparathyroidism (PHPT) with bone lesions 
corresponding to advanced form of OFC. A hypoechoic 
focal lesion in the right lobe of the thyroid was shown on 
the neck ultrasound (Fig. 4). The histological structure of the 
bone tumor resembled giant-cell tumor of bone, however 
negative result of H3F3A mutational testing together with 
clinical presentation allowed to confirm the diagnosis of the 
brown tumor of PHPT. 
The patient was referred to the Department of Endocrine 
Surgery where parathyroidectomy was performed (Fig. 5). 
After the surgery, iPTH levels decreased significantly, which 
spoke in favor for the effectiveness of treatment (Tab. I). 
Histopathology revealed the adenoma of the inferior right 
parathyroid gland. 
Postoperatively administration of vitamin D, alfacalcidol, 
calcium carbonate, magnesium was started. The symptoms 
of hungry bone syndrome with low serum calcium and 
Figure 1. MRI of the pelvis: an osteolytic lesion of about 7.5 cm 
(arrows) in the left iliac bone at the level of the sacro-iliac joint; the 
cystic parts of the tumor contained fluid of various signal intensity 
(fluid-fluid levels) 
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Figure 3. Histopathologic specimens — giant multinucleated cells are spread among small ovoid cells; areas of blood extravasation as well as 
newly formed bone trabeculae are also visible. A. HE 200x B. HE 40x
phosphate levels were observed. The patient was discharged 
home. Further endocrinological treatment, orthopedic con-
sultation and radiological control were all recommended. 
Discussion
PHPT is most frequently diagnosed in middle-aged 
women, in youths it occurs rarely [10, 11]. Non-specific 
symptoms and lack of routine tests of serum calcium in 
young patients make an early diagnosis of this disease very 
difficult. Moreover, pathological features of brown tumor 
and giant cell tumor of bone are very similar. 
In patients suffering from PHPT, first symptoms result from 
hypercalcemia. They are non-specific and often underestimat-
ed both by doctors and patients. Changes in mental status, 
gastrointestinal complaints (such as constipation, anorexia, 
heartburn, nausea, vomiting as well as peptic ulcer disease) 
Figure 2. Delayed phase of 99mTc MDP bone scanning: numerous foci of pathological radioisotope uptake (left iliac bone, left shoulder, right ribs: 
the 6th and the 11th, proximal part of the left tibia)
A. B.
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Figure 5. Excision of the tumor of right inferior parathyroid gland
may be present [5]. The symptoms from bones and kidneys 
gradually increase, however emotional instability, especially 
in young patients, or rigorous dieting, as in the case of our 
patient, are often perceived as the main problem by physicians. 
Young age of patient affected with PHPT should lead 
to consideration of inherited causes, including multiple 
endocrine neoplasia type I and type II, as it can be the first 
component of the syndrome [12].
Conclusions 
Bone tumor in this young woman showed to be a brown 
tumor resulting from PHPT: an advanced form of OFC being 
an effect of intensive bone resorption. 
Brown tumors of bone are an unexpected radiological 
finding. They can occur as multiple or, rarely, solitary bone 
cavities with solid component, presenting as destructive 
bone lesions, mimicking tumors of distending and infiltra-
tive growth [13]. The suspicion of disseminated neoplastic 
disease may be strengthened after bone scintigraphy is 
performed. The results of serum calcium and iPTH are crucial 
for correct management. 
The final diagnosis of bone tumors should be based on 
a synthesis of clinical presentation, imaging characteristics 
and histopathologic findings, preferably in the setting of 
a  multidisciplinary team. Immunohistochemical and ge-
netic/molecular genetic techniques are important for the 
definite classification of certain bone tumors [14].
The treatment of PHPT relies on the excision of patholo-
gically changed parathyroid glands. As a rule, brown tumors 
of bones undergo spontaneous healing with the resorption 
of the soft tissue component, however surgical intervention 
may be needed in cases when long bones or vertebrae 
distention puts them at risk of fracture [15]. 
Figure 4. Neck ultrasound: focal hypoechoic lesion (asterisc) in the inferior pole of the right lobe of the thyroid, adjacent to the trachea
Table I. Preoperative and postoperative concentration of serum calcium and intact PTH
Blood test results (reference range) Preoperatively Postoperatively 3rd day after the surgery
Total serum calcium (2.2–2.65 mmol/l)* 4.11 mmol/l 2.8 mmol/l 2.29 mmol/l
iPTH (12–88 pg/ml)** 989 pg/ml < 6.0 pg/ml 16 pg/ml
* Beckman Coulter, ** Access Intact PTH, Beckman Coulter
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